NT-3 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
K252a is a selective Trk receptor inhibitor that indirectly modulates NT-3 signaling. By inhibiting Trk receptors, K252a interferes with the downstream activation of pathways, such as MAPK and PI3K, which are crucial for NT-3-mediated cellular responses, providing an indirect means to influence NT-3 signaling and downstream effects. | ||||||
GW-441756 | 504433-23-2 | sc-200683 sc-200683A | 10 mg 50 mg | $141.00 $565.00 | 3 | |
GW441756 is a small-molecule Trk receptor inhibitor that disrupts NT-3 signaling. By specifically targeting Trk receptors, GW441756 hinders the activation of downstream signaling cascades, including MAPK and PI3K pathways, resulting in the inhibition of NT-3-mediated cellular responses and providing a direct means to modulate NT-3 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, a downstream effector in the NT-3 signaling pathway. By blocking PI3K activity, LY294002 disrupts the intracellular signaling initiated by NT-3 binding to its receptors, leading to the inhibition of NT-3-mediated cellular processes. This compound offers a direct means to interfere with NT-3 signaling through the PI3K pathway. | ||||||
K-252b | 99570-78-2 | sc-200585 sc-200585A | 100 µg 1 mg | $184.00 $612.00 | 1 | |
K252b, similar to K252a, is a Trk receptor inhibitor that indirectly modulates NT-3 signaling. By targeting Trk receptors, K252b disrupts the downstream activation of pathways essential for NT-3-mediated cellular responses. This indirect inhibition highlights K252b as a compound capable of influencing NT-3 signaling through the modulation of Trk receptor activity. | ||||||
Ro 08-2750 | 37854-59-4 | sc-203682 sc-203682A | 1 mg 10 mg | $188.00 $416.00 | 1 | |
Ro 08-2750 is a selective Trk receptor inhibitor that directly influences NT-3 signaling. By inhibiting Trk receptors, Ro 08-2750 specifically disrupts the downstream signaling pathways activated by NT-3, providing a direct means to modulate NT-3-mediated cellular responses. This compound offers targeted inhibition of NT-3 signaling through Trk receptors. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor that indirectly influences NT-3 signaling through the MAPK pathway. By blocking MEK1/2, U0126 disrupts the downstream activation of MAPK, a pathway critical for NT-3-mediated cellular responses. This indirect inhibition positions U0126 as a compound capable of modulating NT-3 signaling through interference with the MAPK pathway. | ||||||
SU 5402 | 215543-92-3 | sc-204308 sc-204308A | 1 mg 5 mg | $63.00 $98.00 | 36 | |
SU 5402 is a fibroblast growth factor receptor (FGFR) inhibitor that indirectly affects NT-3 signaling. By targeting FGFR, SU 5402 disrupts cross-talk between FGFR and Trk receptors, leading to an indirect inhibition of NT-3-mediated cellular responses. This compound highlights the interconnectedness of signaling pathways and provides an indirect means to influence NT-3 signaling through FGFR inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a non-specific PI3K inhibitor that directly modulates NT-3 signaling through the PI3K pathway. By inhibiting PI3K, Wortmannin disrupts the intracellular signaling initiated by NT-3 binding to its receptors, providing a direct means to interfere with NT-3-mediated cellular processes. This compound offers targeted inhibition of NT-3 signaling through the PI3K pathway. | ||||||
Tyrphostin AG 879 | 148741-30-4 | sc-3557 sc-3557A | 5 mg 25 mg | $83.00 $328.00 | 4 | |
AG 879 is a selective ErbB2 inhibitor that indirectly influences NT-3 signaling. By targeting ErbB2, AG 879 disrupts cross-talk between ErbB2 and Trk receptors, leading to an indirect inhibition of NT-3-mediated cellular responses. This compound highlights the interconnectedness of signaling pathways and provides an indirect means to modulate NT-3 signaling through ErbB2 inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a selective MEK1 inhibitor that indirectly modulates NT-3 signaling through the MAPK pathway. By inhibiting MEK1, PD 98059 disrupts the downstream activation of MAPK, a pathway crucial for NT-3-mediated cellular responses. This indirect inhibition positions PD 98059 as a compound capable of modulating NT-3 signaling through interference with the MAPK pathway. | ||||||